Accompanied by UW School of Medicine and Public Health physician scholars Sara McCoy and Randall Kimple, Jacques Galipeau presented on October 7th at Alliance for Regenerative Medicine on the MESA meeting in Phoenix the results …
Year: 2024
McDowell becomes inaugural Honorary Fellow of Regulatory Affairs
Kimberly McDowell PhD is the inaugural Honorary Fellow of Regulatory Affairs as of October 1 2024, having retired as Director following five years of glorious service with UW Program for Advanced Cell Therapy. Dr. McDowell …
UW PACT Recruiting for Regulatory Scientist
UW Program for Advanced Cell Therapy has an open position for a Regulatory Scientist. Join a dynamic team led by Jacques Galipeau pushing forward innovative cell therapies for cancer survivors and other disorders. Interested candidates …
UW Program for Advanced Cell Therapy (PACT) secures new FDA IDE to restore innate immunity post allogeneic BMT
On July 2 2024 FDA CBER approved the PACT-sponsored Investigational Device Exemption (IDE) application # 30707 named “Allogeneic, TCR αβ and CD19+ cell-depleted peripheral blood mononuclear cells”. Allogeneic BMT patients receiving post-transplant cyclophosphamide to reduce risk …
PACT Completes Pilot Study of Second Dose of MSC for Dry Mouth
UW Program for Advanced Cell Therapy milestone met of sixth and last pilot study (NCT04489732) subject receiving a second administration of autologous MSC in salivary gland to treat radiation-induced dry mouth. In this pilot study, …
PACT to present at ISCT Annual Meeting Next Week
UW Program for Advanced Cell Therapy sponsored pilot clinical trial update gets oral presentation at ISCT, International Society for Cell & Gene Therapy global meeting in Vancouver on May 30, 2024. The abstract “A pilot, first …
From a MARSH a MSC phoenix may arise
On February 1, 2024, the UW Program for Advanced Cell Therapy sponsored MARSH phase 1 clinical trial treated its first patient at UW Carbone Cancer Center. This National Institute of Dental and Craniofacial Research (NIDCR) …